Why High Dividend Yield ETFs Can Be an Effective Replacement for the Value Factor

How does DHS work?

Unlike typical market-cap weighted ETFs, DHS allocates its holdings based on the proportionate share of the aggregate cash dividends that each component company is projected to pay in the coming year.

This is based on the most recently declared dividends per share, which inherently steers the fund towards companies that not only pay significant dividends but are also able to sustain and potentially grow them.

To refine its selection and weighting strategy, DHS employs a "composite risk score." This score integrates assessments of value, quality, and momentum, and it's used to adjust the weightings of holdings, capped at 5% during the annual rebalance.

The quality component is measured within industry groups by examining trends in return on equity (ROE), return on assets (ROA), gross profits over assets, and cash flows over assets.

These metrics are critical as they indicate the financial health and efficiency of a company, ensuring that the high dividends are not only sustainable but are also being generated by fundamentally strong enterprises.

The inclusion of momentum—risk-adjusted total returns over historical periods of 6 and 12 months—is particularly vital in a fundamentally driven strategy. It helps ensure that the investment does not run counter to prevailing market trends, which can be a significant risk in value-driven investment strategies.

This multi-dimensional approach to selecting high-dividend-paying stocks is crucial. Relying solely on high dividend yields can lead to "value traps," where a stock's price has fallen significantly, inflating the dividend yield temporarily until a likely cut.

By integrating quality and momentum filters with dividend yield considerations, DHS provides a robust framework that mitigates these risks.

How much value exposure does DHS provide?

The factor regression summary presented below demonstrates the WisdomTree US High Dividend ETF

1. Value Exposure (HML - High Minus Low):

• DHS shows a significant exposure to the value factor with an HML loading of 0.34. This is marginally higher than other renowned value ETFs like the SPDR Portfolio S&P 500 Value ETF
  SPYV
  +0.51%
  and the iShares MSCI USA Value Factor ETF
  VLUE
  +1.9%
  , which exhibit HML loadings of 0.29 and 0.32, respectively. Although the difference may appear modest, it indicates that DHS effectively captures the value factor, positioning it as a solid alternative or complement to these more traditional value-focused ETFs.

1. Quality and Investment Factors:

• Beyond just value, DHS also incorporates a "composite risk score" that evidently contributes to palpable exposures to quality and investment factors, specifically RMW (Robust Minus Weak) and CMA (Conservative Minus Aggressive).
• RMW (0.20): This factor measures profitability, where DHS's loading of 0.20 is higher than the dedicated quality factor ETF, iShares MSCI USA Quality Factor ETF
  QUAL
  +0.73%
  , which has an RMW loading of 0.19. This suggests that DHS not only seeks value stocks but also those with solid profitability, enhancing its appeal to investors looking for quality in value stocks.
• CMA (0.34): Representing investment conservatism, DHS's CMA loading is significantly higher than the other ETFs listed, including the multifactor Vanguard US Multifactor ETF
  VFMF
  +0.88%
  , which has a CMA loading of 0.05. This highlights DHS's preference for companies that are prudent in their asset growth strategies, aligning with a lower risk profile.

This combination of exposures makes DHS not just a straightforward high-dividend yield or pure value play; it strategically targets companies exhibiting both value and quality characteristics, potentially offering a more balanced and risk-mitigated approach to value investing.

Please note this article is for information purposes only and does not in any way constitute investment advice. It is essential that you seek advice from a registered financial professional prior to making any investment decision.